Daniel J. Abdun-Nabi

2014

In 2014, Daniel J. Abdun-Nabi earned a total compensation of $4.1M as President and Chief Executive Officer at Emergent BioSolutions, a 92% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$489,610
Option Awards$1,229,190
Salary$690,554
Stock Awards$1,730,232
Other$7,800
Total$4,147,386

Abdun-Nabi received $1.7M in stock awards, accounting for 42% of the total pay in 2014.

Abdun-Nabi also received $489.6K in non-equity incentive plan, $1.2M in option awards, $690.6K in salary and $7.8K in other compensation.

Rankings

In 2014, Daniel J. Abdun-Nabi's compensation ranked 2,030th out of 13,032 executives tracked by ExecPay. In other words, Abdun-Nabi earned more than 84.4% of executives.

ClassificationRankingPercentile
All
2,030
out of 13,032
84th
Division
Manufacturing
713
out of 4,966
86th
Major group
Chemicals And Allied Products
224
out of 1,686
87th
Industry group
Drugs
171
out of 1,365
88th
Industry
Pharmaceutical Preparations
142
out of 1,043
86th
Source: SEC filing on April 13, 2017.

Abdun-Nabi's colleagues

We found five more compensation records of executives who worked with Daniel J. Abdun-Nabi at Emergent BioSolutions in 2014.

2014

Fuad El-Hibri

Emergent BioSolutions

Chairman

2014

Robert Kramer

Emergent BioSolutions

Chief Financial Officer

2014

Robert Kramer

Emergent BioSolutions

Chief Financial Officer

2014

Barry Labinger

Emergent BioSolutions

Executive Vice President, Biosciences Division

2014

Adam Havey

Emergent BioSolutions

Executive Vice President, Business Operations

News

You may also like